In vitro studies on multiple myeloma cell lines and purified CD38 protein have shown that ISA inhibits both CD38 hydrolase and cyclase activity, while DARA only partially inhibits cyclase activity and enhances hydrolase activity.20, 39. This evidence concerns the gene CD38 and plasma cell myeloma.